SAN

92.07

+0.01%↑

SHL.DE

48.88

-0.69%↓

ARGX

505.4

+0.48%↑

FRE

43.11

+0.47%↑

ONC.US

228.61

+1.33%↑

SAN

92.07

+0.01%↑

SHL.DE

48.88

-0.69%↓

ARGX

505.4

+0.48%↑

FRE

43.11

+0.47%↑

ONC.US

228.61

+1.33%↑

SAN

92.07

+0.01%↑

SHL.DE

48.88

-0.69%↓

ARGX

505.4

+0.48%↑

FRE

43.11

+0.47%↑

ONC.US

228.61

+1.33%↑

SAN

92.07

+0.01%↑

SHL.DE

48.88

-0.69%↓

ARGX

505.4

+0.48%↑

FRE

43.11

+0.47%↑

ONC.US

228.61

+1.33%↑

SAN

92.07

+0.01%↑

SHL.DE

48.88

-0.69%↓

ARGX

505.4

+0.48%↑

FRE

43.11

+0.47%↑

ONC.US

228.61

+1.33%↑

Search

Pharming Group NV

Atvērts

0.851 -0.12

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.835

Max

0.863

Galvenie mērījumi

By Trading Economics

Ienākumi

4.3M

3.4M

Pārdošana

18M

93M

EPS

-0.02

Peļņas marža

3.657

Darbinieki

404

EBITDA

1.9M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+135.77% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 31. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

119M

609M

Iepriekšējā atvēršanas cena

0.97

Iepriekšējā slēgšanas cena

0.851

Pharming Group NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 18. maijs 23:47 UTC

Tirgus saruna

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

2025. g. 18. maijs 23:40 UTC

Tirgus saruna

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

2025. g. 18. maijs 18:00 UTC

Peļņas

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

2025. g. 18. maijs 17:01 UTC

Top Ziņas

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

2025. g. 18. maijs 16:20 UTC

Peļņas

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

2025. g. 18. maijs 12:09 UTC

Top Ziņas

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

2025. g. 17. maijs 17:15 UTC

Top Ziņas

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

2025. g. 17. maijs 09:30 UTC

Top Ziņas
Peļņas

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

2025. g. 17. maijs 08:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. maijs 08:20 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 16. maijs 23:18 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

2025. g. 16. maijs 22:30 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- Update

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

2025. g. 16. maijs 21:56 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. maijs 21:54 UTC

Top Ziņas

U.S. Loses Last Triple-A Credit Rating -- WSJ

2025. g. 16. maijs 21:22 UTC

Tirgus saruna

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

2025. g. 16. maijs 21:17 UTC

Tirgus saruna

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

2025. g. 16. maijs 21:17 UTC

Top Ziņas

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

2025. g. 16. maijs 21:05 UTC

Tirgus saruna

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

2025. g. 16. maijs 20:55 UTC

Iegādes, apvienošanās, pārņemšana

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025. g. 16. maijs 20:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 16. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 16. maijs 20:37 UTC

Top Ziņas

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

2025. g. 16. maijs 20:33 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

2025. g. 16. maijs 20:30 UTC

Iegādes, apvienošanās, pārņemšana

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

2025. g. 16. maijs 20:18 UTC

Top Ziņas

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

2025. g. 16. maijs 20:16 UTC

Top Ziņas

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

2025. g. 16. maijs 20:15 UTC

Peļņas

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

2025. g. 16. maijs 20:11 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: William K. Daniel Joins Board

2025. g. 16. maijs 20:10 UTC

Iegādes, apvienošanās, pārņemšana

Henry Schein: Strategic Investment by KKR Completed

Salīdzinājums

Cenas izmaiņa

Pharming Group NV Prognoze

Cenas mērķis

By TipRanks

135.77% augšup

Prognoze 12 mēnešiem

Vidējais 2.004 EUR  135.77%

Augstākais 2 EUR

Zemākais 2 EUR

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Pharming Group NV — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

1 ratings

1

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.